Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

AEterna, Zentaris Enter Another LHRH Product Deal With Solvay

Jan. 26, 2004

By Aaron Lorenzo

Genaera Gains $20M Through Direct Stock Equity Placement

Jan. 23, 2004

By Aaron Lorenzo

Genaera Gains $20M Through Direct Stock Equity Placement

Jan. 23, 2004

By Aaron Lorenzo

Cellular Genomics' Initial Close Of Series C Gathers Up $22.3M

Jan. 22, 2004

By Aaron Lorenzo

Cellular Genomics' Initial Close Of Series C Gathers Up $22.3M

Jan. 22, 2004

By Aaron Lorenzo

Genentech Beats 4Q Estimates, Files To Expand Nutropin Label

Jan. 16, 2004

By Aaron Lorenzo

Genentech Inc. released year-end and quarterly earnings that beat consensus estimates, simultaneously disclosing its application for an expanded indication of one of its growth hormone products. (BioWorld Today)

Genentech Beats 4Q Estimates, Files To Expand Nutropin Label

Jan. 16, 2004

By Aaron Lorenzo

Genentech Inc. released year-end and quarterly earnings that beat consensus estimates, simultaneously disclosing its application for an expanded indication of one of its growth hormone products. (BioWorld Today)

OxiGene Gets $22.3M, Plans Expansion Of CA4P Program

Jan. 15, 2004

By Aaron Lorenzo

OxiGene Gets $22.3M, Plans Expansion Of CA4P Program

Jan. 15, 2004

By Aaron Lorenzo

Curis Inks $170M Deal To License Hedgehog Technology To Wyeth

Jan. 14, 2004

By Aaron Lorenzo

View All Articles by Aaron Lorenzo